Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

serous effusion

Known as: effusions serous 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
  • J. Li, W. Zhang, +4 authors X. Su
  • Cytopathology : official journal of the British…
  • 2019
  • Corpus ID: 115206429
The objective of this study is to evaluate the effectiveness of diagnosing Burkitt lymphoma (BL) in serous effusion (SE) specimen… Expand
2019
2019
Objective: Immunocytochemistry (ICC) of serous effusion is an important tool for the diagnosis of benign and malignant cells. Our… Expand
  • table 1
  • figure 1
  • figure 2
  • figure 3
  • table 2
2018
2018
  • J. Li, W. Zhang, +7 authors X. Su
  • Cytopathology : official journal of the British…
  • 2018
  • Corpus ID: 4357763
Acute lymphoblastic leukaemia/lymphoma (ALL/LBL) is an aggressive entity of precursor lymphoid neoplasm and may cause malignant… Expand
Review
2018
Review
2018
Background: Epithelioid hemangioendothelioma (EHE) involving serous effusion is extremely rare, and the diagnosis can be… Expand
2013
2013
Dear Editor, HIVor HHV-8-related primary effusion lymphoma (PEL) is a rare and poor prognostic disease which presents as serous… Expand
  • figure 1
Review
2013
Review
2013
Metastatic urothelial carcinoma (UC) to serous effusion (SE) is extremely rare and its cytomorphological features have only been… Expand
2011
2011
Primary effusion lymphoma (PEL) is a rare type of non-Hodgkin lymphoma usually confined to the body cavities of predominantly… Expand
2010
2010
Objectives While other cytokines are known to be associated with otitis media with effusion (OME), the involvement of heat shock… Expand
  • figure 1
  • figure 2
  • table 1
  • table 2
  • table 3
1999
1999
BACKGROUND Granulocytic sarcoma (GS) is the rare extramedullary manifestation of acute myeloid leukemia that may precede or be… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4